FIG. S1. Examination of the periodic expression of NadA-2/3, NadA-1 and NadA-4/5 peptide variants by Western blot analysis. Subsets of meningococcal isolates were selected based on repeat number. Repeat numbers were confirmed by GeneScan analysis and sequencing. NadA expression was determined by Western blot and quantified by densitometry. NadA bands were normalised against Hsp90 bands and then relative density was assessed against either (A) M14 240602 (MenW) or (B) M12 240277 (MenB).
(A) NadA expression in isolates expressing NadA-2/3 peptides. (B) NadA expression in isolates expressing either NadA-1 or NadA-4/5 peptides. 0 represents isolates not expressing a NadA peptide due to stop codons in the reading frame. Numbers in brackets represent the 5'TAAA repeat number. Each bar represents four biological replicates, mean + SEM.
FIG. S2. Examination of NadA expression for MATS-tested NadA isolates by Western blot analysis. Subsets of meningococcal isolates were selected based on previous MATS testing and repeat number. Repeat numbers were confirmed by GeneScan analysis and sequencing. NadA expression was determined by Western blot and quantified by densitometry. NadA bands were normalised against Hsp90 bands and then relative density was assessed against M14 240527. (A) NadA expression in isolates expressing 
